Found 5 matching trials
Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over N/A The aim of the study is to compare, in real life, the risk benefit (includi...
Show More Location
Assistance Publique Hôpitaux de Paris
Learn More & Join Trial
Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion PHASE3 A study for patients with abnormal heart rhythm (atrial fibrillation) who n...
Show More Location
Multiple Locations
Learn More & Join Trial
Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension N/A Pulmonary hypertension (PHT) patients often receive long term oral anticoag...
Show More Location
CHU Clermont-Ferrand
Learn More & Join Trial
Anticoagulant Clinics and Vitamin K Antagonists PHASE4 Background: Whether the management of vitamin K antagonists (VKA) therapy b...
Show More Location
University Hospital
Learn More & Join Trial
Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus PHASE3 Left ventricular thrombus is found in 10 to 25% of patients with impaired l...
Show More Status
Active Not Recruiting
Learn More & Join Trial